Zoekresultaten - 198 results
Coadministered pneumococcal conjugate vaccine decreases immune response to hepatitis A vaccine: a randomized controlled trial.
immunogenicity of the most common travellers’ vaccine hepatitis A (HepA) and the pneumococcal conjugate vaccine (PCV) increasingly used both at home and before travel. METHODS: Volunteers aged ≥18 years (n = 305) ...
Urine concentrations of Arsenic and its species in adolescents from Wallonia (Belgium).
inorganic arsenic) in a sample of 281 adolescents (aged 12-19y) for the BMH- WAL survey (2019-2020) using inductively coupled plasma mass spectrometry. The participants completed self-administered ...
Pollutant exposure and myocardial injury: Protocol and progress report for a toxicological systematic mapping review.
while CVD incidence rises steadily with the aging population. Although numerous experimental studies are now available, the mechanisms through which lifetime exposure to environmental pollutants can ...
HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial.
Organised Cervical Cancer Screening Programme (OCCSP) was started in Poland in 2006/2007. Each woman aged 25 to 59 is eligible for a free Pap test every 3 years in OCCSP. Despite implementation of the OCCSP, ...
Factors underlying COVID-19 booster vaccine uptake among adults in Belgium
Source: BMC Res Notes, Volume 16, Issue 1 (2023) Keywords: Adult Aged Belgium Biological Transport COVID-19 COVID-19 Vaccines Female Humans Immunization Programs Male Vaccination Abstract: OBJECTIVE: This ...
The overweight epidemic increasingly hits children of lower educated parents in Belgium
include children aged 2-17 years. The highest educational level among parents is used as a proxy for SES and is dichotomized into lower (at most a higher secondary degree versus high (higher education). ...
Comparing frailty prevalence between countries: validation of the Global Burden of Disease study Frailty Index (GBD-FI) in the survey of health, ageing and retirement in Europe
Publication Type: Peer reviewed scientific article Authors: Mark R O'Donovan; Brecht Devleesschauwer; Duygu Sezgin; Aaron Liew; Zubair Kabir; Rónán O'Caoimh Source: Age Ageing, Volume 52, ...
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Anthony; Nicolay, Nathalie; Monge, Susana; VEBIS-Lot4 working group Source: Influenza Other Respir Viruses, Volume 17, Issue 11 (2023) Keywords: Aged COVID-19 COVID-19 Vaccines Electronics Hospitalization ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
last PSV dose). We measured VE overall, by vaccine category/product, age group and time since first mRNA booster dose, adjusting by site as a fixed effect, and by swab date, age, sex, and ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
the Alpha period, VE against hospitalisation with SARS-CoV2 for complete Comirnaty PSV was 85% (95% CI: 69-92) overall and 75% (95% CI: 42-90) in those aged ≥ 80 years. During the Delta period, among ...